Is Tumor Sidedness, Biomarkers or Molecular Subtype Classification More Predictive for the Treatment of Unresectable Metastatic Colon Cancer?
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Gokhan Demir
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Gokhan Demir
Login to view comments.
Click here to Login